CURAXIS PHARMACEUTICAL CORP
CIK 0001434893
Revenue (TTM)
—
Q1 May 2012
Net Income (TTM)
−$893K
+159.4% YoY
Q1 May 2012
EPS Diluted (TTM)
−$0.02
+166.7% YoY
Q1 May 2012
Gross Margin
—
Q1 May 2012
Operating Margin
—
Q1 May 2012
Net Margin
—
Q1 May 2012
Free Cash Flow (TTM)
−$2.05M
Q1 May 2012
Cash
$11K
Q1 May 2012
Total Debt
—
Q1 May 2012
Shares Outstanding
83.55M sh
Q1 May 2012
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.